Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(NY: FOXO )

0.5989 -0.0611 (-9.26%)
Official Closing Price Updated: 8:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about FOXO

< Previous 1 2 Next >
FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company’s Epigenetic Data with the Power of AI
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Inc. Announces Reverse Stock Split
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Announces Agreement With Atrio Insurance
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity
From FOXO Technologies
Via Business Wire
FOXO Technologies™ Announces Second Quarter 2023 Financial Results
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies™ Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT
From FOXO Technologies Inc.
Via Business Wire
Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Announces Results of Annual Stockholders Meeting
From FOXO Technologies Inc.
Via Business Wire
NYSE American Has Commenced Delisting Proceedings in the FOXO WS warrants of FOXO Technologies Inc.
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies™ Announces First Quarter 2023 Financial Results
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies™ Announces Resignation of Taylor Fay, Chief Operating Officer
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Announces Direct-to-Consumer Launch of Longevity Report Beta Product
From FOXO Technologies Inc.
Via Business Wire
FOXO Technologies Inc. (FOXO) Class Acton Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against FOXO Technologies Inc.
From Robbins LLP
Via Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against FOXO Technologies Inc. (FOXO)
From Robbins LLP
Via Business Wire
FOXO Technologies™ Announces Full Year 2022 Financial Results and Recent Business Highlights
From FOXO Technologies Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.